Childhood Cancer Therapeutic Catalyst supports academic researchers in collaborative early drug discovery to advance novel therapeutics for children and young people with cancer.
Therapeutic Catalyst supports academic researchers in early drug discovery, funding target identification, validation and early antibody or small molecule development to advance treatments for adult cancers.
Childhood Cancer Research Grants support investigators, including beginning scientists and physician-scientists, in targeted research to improve childhood cancer survival while protecting long-term health.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
A Collaborative Pediatric Cancer Research Awards Program supports fellows, investigators, and consortia studying childhood cancers to advance discoveries, safer treatments, and patients’ quality of life.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.